designing an experiment testing the effectiveness of a drug in phase 3 clinical trials

Name of Student
Professor’s Name
Clinical Trial
27th October, 2015
Designing an Experimentation Testing the Effectiveness of a Drug in Phase 3 Clinical Trial
Materials and Methodology
Selection of Samples
3000 individuals suffering from lung cancer were selected through purposive sampling. The subjects were selected from the Santa Clara Medical Centre. Lung cancer was standardized as a significant tumorous growth in any part of the lungs which was certified by the consultant radiologist as per carcinoma guidelines. The individuals were randomized into various groups as per the protocol of experimental design. Each completing the study was compensated with 500$ for their time during the study period of 1.5 years. A written consent was obtained from each participant as per the protocol of ethical research.

Inclusion Criteria
Individuals aged between 30 years to 60 years were included in the study. Only such individuals were selected, in whom, tumor biomass was significantly diagnosed by the consultant radiologist. Smokers and non-smokers were both included in the study to reduce the effects of confounding bias. Further, male and females were included in the study to reduce the chances of gender bias.
Exclusion Criteria
Individuals below the age of 30 years and more than 60 years were excluded from the trial. Such exclusion criteria were based on phase 2 data, where the safety profiles in such age groups were not conclusive. Moreo…